NCT05415202View on ClinicalTrials.gov

Remimazolam Sedation for Nerve Blocks

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 6, 2022

Primary Completion Date

August 1, 2022

Study Completion Date

August 1, 2022

Conditions
Procedural AnxietyProcedural Pain
Interventions
DRUG

Remimazolam 20 MG [Byfavo]

Remimazolam will be administered for sedation and efficacy and safety will be recorded

Trial Locations (1)

84132

University of Utah, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER